Windtree Therapeutics Files S-1/A Amendment
Ticker: WINTW · Form: S-1/A · Filed: Apr 24, 2025 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | S-1/A |
| Filed Date | Apr 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, registration, amendment
TL;DR
Windtree Therapeutics filed an S-1/A. Looks like they're still working on their registration.
AI Summary
Windtree Therapeutics, Inc. filed an S-1/A amendment on April 24, 2025, for its registration statement. The company, formerly known as Discovery Laboratories Inc., is incorporated in Delaware and operates in the biological products sector. Its principal executive offices are located at 2600 Kelly Road, Suite 100, Warrington, Pennsylvania.
Why It Matters
This filing indicates ongoing regulatory and financial activities for Windtree Therapeutics, which could impact its stock and future business operations.
Risk Assessment
Risk Level: medium — S-1/A filings often relate to capital raises or significant corporate changes, which inherently carry risk for investors.
Key Numbers
- 2836 — SIC Code (Biological Products (No Diagnostic Substances))
- 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
Key Players & Entities
- WINDTREE THERAPEUTICS INC /DE/ (company) — Registrant
- 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 (company) — Business Address
- Jed Latkin (person) — President and Chief Executive Officer
- Discovery Laboratories Inc /DE/ (company) — Former Company Name
- 333-284976 (dollar_amount) — SEC File Number
FAQ
What is the purpose of this S-1/A filing?
This is an amendment to a registration statement filed under the Securities Act of 1933, indicating ongoing efforts related to securities registration.
When was this amendment filed?
The filing was made on April 24, 2025.
What is Windtree Therapeutics' primary business classification?
The company's Standard Industrial Classification (SIC) code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What was Windtree Therapeutics previously known as?
The company was formerly known as Discovery Laboratories Inc. /DE/.
Where are Windtree Therapeutics' principal executive offices located?
The principal executive offices are located at 2600 Kelly Road, Suite 100, Warrington, Pennsylvania, 18976.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on April 24, 2025 by Jed Latkin regarding WINDTREE THERAPEUTICS INC /DE/ (WINTW).